Alendronate, Sodium Salt is a nitrogen-containing bisphosphate that acts as a robust inhibitor of bone reabsorption and induces apoptosis in osteoclasts, among other cell types, by modification of GTP-binding proteins post-transcriptionally. The compound has been shown to act as a selective inhibitor of FDPS (farnesyl diphosphate synthase). Prostate cancer studies also revealed that Alendronate inhibits the migration and invasion of PC-3 cells (sc-2220) by interfering with the mevalonate pathway. Additionally, Alendronate, Sodium Salt is an inhibitor of CD45RC and MMP.
1. Bergstrom, J.D., et al. 2000. Arch. Biochem. Biophys. 373: 231-241. PMID: 10620343
2. Virtanen, S.S., et al. 2002. Cancer Res. 62: 2708-2714. PMID: 11980672
3. Lehenkari, P.P., et al. 2002. Mol. Pharmacol. 61: 1255-1262. PMID: 11961144
4. Ma, Y.L., et al. 2003. Endocrinology. 144: 2008-2015. PMID: 12697709
See how others have used Alendronate, Sodium Salt. Click on the entry to view the PubMed entry .
PMID: # 9874784 Fisher, JE. et al. 1999. Proc. Natl. Acad. Sci. U.S.A. 96: 133-138.
PMID: # 8950879 Black, DM. et al. 1996. Lancet. 348: 1535-1541.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.